Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Eric K. Hoobler"'
Autor:
Eric K Hoobler, Ganesha Rai, Andrew G S Warrilow, Steven C Perry, Christopher J Smyrniotis, Ajit Jadhav, Anton Simeonov, Josie E Parker, Diane E Kelly, David J Maloney, S L Kelly, Theodore R Holman
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e65928 (2013)
We report the discovery of a novel dual inhibitor targeting fungal sterol 14α-demethylase (CYP51 or Erg11) and human 5-lipoxygenase (5-LOX) with improved potency against 5-LOX due to its reduction of the iron center by its phenylenediamine core. A s
Externí odkaz:
https://doaj.org/article/7993a077535548118bd36c4560fa1ddb
Autor:
Lena Schultz, William Leister, Eric K. Hoobler, Ganesha Rai, David J. Maloney, Ajit Jadhav, Anton Simeonov, Victor Kenyon, J. Brian Jameson, Theodore R. Holman, Michelle Armstrong
Publikováno v:
Journal of Medicinal Chemistry. 53:7392-7404
There are a variety of lipoxygenases in the human body (hLO), each having a distinct role in cellular biology. Human reticulocyte 15-Lipoxygenase-1 (15-hLO-1), which catalyzes the dioxygenation of 1,4-cis,cis-pentadiene-containing polyunsaturated fat
Autor:
Eric K. Hoobler, Karen Tenney, Sarah J. Robinson, Theodore R. Holman, Michelle Riener, Frederick A. Valeriote, Phillip Crews, Steven T. Loveridge
Publikováno v:
Journal of Natural Products. 72:1857-1863
Enzyme screening of crude sponge extracts prioritized a 2005 Papua New Guinea collection of Hyrtios sp. for further study. The MeOH extract contained puupehenone and four puupehenone analogues (1, 2, 3, 5, and 7) along with a new diastereomer, 20-epi
Autor:
Silvia Sepúlveda-Boza, Eric K. Hoobler, Theodore R. Holman, Carolina Mascayano, Giovanni Diaz, Victoria Espinosa, Steve Perry
Publikováno v:
Chem Biol Drug Des
Chemical biology & drug design, vol 86, iss 1
Mascayano, C; Espinosa, V; Sepúlveda-Boza, S; Hoobler, EK; Perry, S; Diaz, G; et al.(2015). Enzymatic studies of isoflavonoids as selective and potent inhibitors of human leukocyte 5-lipo-oxygenase. Chemical Biology and Drug Design, 86(1), 894-901. doi: 10.1111/cbdd.12469. UC Santa Cruz: Retrieved from: http://www.escholarship.org/uc/item/7mk9465q
Chemical biology & drug design, vol 86, iss 1
Mascayano, C; Espinosa, V; Sepúlveda-Boza, S; Hoobler, EK; Perry, S; Diaz, G; et al.(2015). Enzymatic studies of isoflavonoids as selective and potent inhibitors of human leukocyte 5-lipo-oxygenase. Chemical Biology and Drug Design, 86(1), 894-901. doi: 10.1111/cbdd.12469. UC Santa Cruz: Retrieved from: http://www.escholarship.org/uc/item/7mk9465q
© 2014 John Wiley & Sons A/S. Continuing our search to find more potent and selective 5-LOX inhibitors, we present now the enzymatic evaluation of seventeen isoflavones (IR) and nine isoflavans (HIR), and their in vitro and in cellulo potency agains
Lipoxygenases, important enzymes in inflammation, can regulate their substrate specificity by allosteric interactions with its own hydroperoxide products. In the current work, addition of both 13-(S) hydroxy-9Z,11E-octadecadienoic acid (13-(S)-HODE)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::360894b0e2b1779b161f5d14d06cebb8
https://europepmc.org/articles/PMC3866584/
https://europepmc.org/articles/PMC3866584/
Autor:
Diane E. Kelly, Andrew G. S. Warrilow, Ganesha Rai, Eric K. Hoobler, Steven L. Kelly, Theodore R. Holman, Ajit Jadhav, David J. Maloney, Josie E. Parker, Anton Simeonov, Christopher J. Smyrniotis, Steve Perry
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 6, p e65928 (2013)
PLoS ONE, Vol 8, Iss 6, p e65928 (2013)
We report the discovery of a novel dual inhibitor targeting fungal sterol 14α-demethylase (CYP51 or Erg11) and human 5-lipoxygenase (5-LOX) with improved potency against 5-LOX due to its reduction of the iron center by its phenylenediamine core. A s
Understanding the mode of action for lipoxygenase (LOX) inhibitors is critical to determining their efficacy in the cell. The pseudoperoxidase assay is an important tool for establishing if a LOX inhibitor is reductive in nature, however, there have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2ddf6396816a1882b35c3636297371c
https://europepmc.org/articles/PMC3781013/
https://europepmc.org/articles/PMC3781013/
Publikováno v:
CHEMICAL BIOLOGY & DRUG DESIGN
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
In this study, we have investigated 16 isoflavone and isoflavan derivatives as potential inhibitors of human lipoxygenase (platelet 12-lipoxygenase, reticulocyte 15-lipoxygenase-1, and epithelial 15-lipoxygenase-2). The flavonoid baicalein, a known l